Related Experiment Video
Updated: Apr 16, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
11.6K
Noninternalizing targeted cytotoxics for cancer therapy
1†Philochem AG, Libernstrasse 3, CH8112 Otelfingen (ZH), Switzerland.
Molecular Pharmaceutics
|March 5, 2015
Summary
Targeted cancer therapies using non-internalizing ligands deliver cytotoxic agents to tumors extracellularly. This approach minimizes toxicity to healthy organs and enhances drug efficacy for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Conventional chemotherapy faces limitations due to poor tumor localization and systemic toxicity.
- Targeted drug delivery aims to improve therapeutic efficacy by concentrating agents at the tumor site.
- Ligand-mediated delivery offers a promising strategy for selective pharmacodelivery.
Purpose of the Study:
- To review the requirements for developing non-internalizing targeted cytotoxic agents.
- To explore the potential of extracellular drug delivery in tumors.
- To highlight strategies for effective release of anticancer drugs in the tumor microenvironment.
Main Methods:
- Literature review of existing research on targeted cancer therapy.
- Analysis of ligand-based drug delivery systems.
- Evaluation of extracellular drug release mechanisms.
Main Results:
- Non-internalizing ligands can facilitate targeted delivery of cytotoxic agents to the tumor extracellular space.
- Extracellular drug delivery, coupled with appropriate release strategies, shows potential for potent anticancer activity.
- Development of these agents requires careful consideration of ligand properties and release kinetics.
Conclusions:
- Non-internalizing targeted cytotoxics represent a promising advancement in cancer chemotherapy.
- This approach offers a strategy to overcome limitations of conventional chemotherapy by enhancing tumor specificity and reducing side effects.
- Further research into the development and application of these targeted agents is warranted.
Keywords:
antibody−drug conjugatescancerdosimetriesdrug quantitative biodistributionnoninternalizing antibody−drug conjugatessmall molecule drug conjugatesMore Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
8.1K
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
1.5K
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
01:27Cytotoxic T Cells-mediated Immune Response
8.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.5K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144